Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

HRT Shrinks the Brain

But research shows it does not damage cerebral blood vessels in older women

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
AIDS and HIV Infection
Alzheimer's Disease
Amenorrhea
More...

Related Healthscout Videos
 border=
Custom Ankle Replacements
Shutting Down Tremor.
Disaster Heart Attacks
Weighted Belt for Autism?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Focusing on School Could Prevent Teen Pregnancies
Low Vitamin D Tied to Estrogen Decline
Caring Through Sharing -- Life Changing Stories
Breast Cancer Pain Continues Years After Treatment
More...

MONDAY, Jan. 12 (HealthDay News) -- Two studies looking at the same group of women found that while hormone therapy is linked with brain shrinkage, it does not seem to be associated with early signs of cerebrovascular disease.

This suggests that hormone therapy's effect on brain volume, not its effect on the brain lesions that indicate "silent strokes," is the mechanism by which hormones increase the risk for dementia in women over 65.

Text Continues Below



"These are a nice companion to cognitive studies reported earlier. This is now neuroradiological evidence that, together, suggest that the effect [of hormones] may be more degeneration than vascular," said Miriam Weber, an assistant professor of physical medicine and rehabilitation and of neurology at the University of Rochester Medical Center.

These papers, both published in the Jan. 13 issue of Neurology, are the latest in a parade of analyses resulting from the hormone therapy arm of the landmark, government-sponsored Women's Health Initiative study.

Previous results included an increased risk of stroke and cerebrovascular disease in women over 65 taking hormone replacement therapy (HRT). Another offshoot of the WHI, the WHI Memory Study, found an increased risk of dementia and memory problems in this group of women.

Both papers set out to understand the mechanisms behind this increased risk for dementia in women taking conjugated equine estrogens (either estrogen alone or estrogen plus progestin).

In the primary paper, researchers analyzed brain scans on about 1,400 women in the WHI Memory Study, who had been on hormone therapy for about four to six years.

They found no relationship between vascular lesions in the brain or an increased risk of dementia.

"The main message is that women over 65 years of age who took CEE-based hormone therapy [either estrogen alone or estrogen plus progestin] through the WHI clinical trials and who agreed to have an MRI scan did not experience increases in brain lesion volume," said study author Laura H. Coker, an assistant professor of public health sciences at Wake Forest University School of Medicine in Winston-Salem, N.C.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 1/12/2009

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





SOURCES: Susan M. Resnick, Ph.D., senior investigator, Intramural Research Program, U.S. National Institute on Aging, Baltimore; Laura H. Coker, Ph.D., assistant professor, public health sciences, Wake Forest University School of Medicine, Winston-Salem, N.C.; Miriam Weber, Ph.D., assistant professor, physical medicine and rehabilitation and neurology, University of Rochester Medical Center; Jan. 13, 2009, Neurology


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy